1-Decene, 1-methoxy-, (1E)-
| Common Name: |
1-Decene, 1-methoxy-, (1E)- |
| IUPAC Name: |
170.29 g/mol |
| Molecular Formula: |
C16H25NO2 |
| SMILES: |
CCCCCCCCC=COC |
| Inchi: |
1S/C11H22O/c1-3-4-5-6-7-8-9-10-11-12-2/h10-11H,3-9H2,1-2H3 |
| Inchi Key: |
OVQHJRCXRNGXRJ-UHFFFAOYSA-N |
| Cas No: |
79930-37-3 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
263.38 |
| Mass (g/mol) |
170.167 |
| Molar Refractivity |
80.58 |
| Net Charge |
|
| HBD |
1 |
| HBA |
2 |
| Rt Bonds |
10 |
| Rings |
|
| TPSA |
52.32 |
| Hetero Atoms |
1 |
| Heavy Atoms |
19 |
| Aromatic Heavy Atoms |
6 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
213.00 to 215.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.222 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.56 |
| LogP |
3.897 |
| iLOGP |
3.55 |
| XLOGP3 |
6.16 |
| WLOGP |
4.18 |
| MLOGP |
3.55 |
| ESOL Log S |
-4.93 |
| ESOL Solubility (mg/ml) |
0.003 |
| ESOL Solubility (mol/l) |
0 |
| ESOL Class: esol_class |
Moderately soluble |
| Ali Log S |
-7.04 |
| Ali Solubility (mg/ml) |
0 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Poorly soluble |
| Silicos-IT LogSw |
-5.36 |
| Silicos-IT Solubility (mg/ml) |
0 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Moderately soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-3.53 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.81 |
| CYP1A2 Inhibitor |
1 |
| CYP2C19 Inhibitor |
1 |
| CYP2C9 Inhibitor |
1 |
| CYP2D6 inhibitor |
1 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.964 |
| Carcinogenicity (Binary) |
1 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
